(0.74%) 5 055.42 points
(0.70%) 38 170 points
(1.27%) 15 803 points
(-0.25%) $78.80
(5.28%) $2.03
(0.29%) $2 317.70
(0.46%) $26.87
(0.97%) $964.15
(-0.02%) $0.933
(-0.28%) $11.00
(-0.01%) $0.798
(-1.35%) $92.00
-17.95% $ 0.660
Live Chart Being Loaded With Signals
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases...
Stats | |
---|---|
Dagens volum | 574 675 |
Gjennomsnittsvolum | 2.39M |
Markedsverdi | 16.15M |
EPS | $-0.600 ( 2024-03-25 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.342 |
ATR14 | $0.0570 (8.64%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-17 | Aselage Steve | Sell | 483 741 | Common Stock, $0.0001 par value per share |
2023-11-17 | Dunn John Michael | Sell | 27 380 | Common Stock, $0.0001 par value per share |
2023-11-17 | Joseph Donald | Sell | 14 285 | Common Stock, $0.0001 par value per share |
2023-11-17 | Schelling Chris | Sell | 2 712 529 | Common Stock, $0.0001 par value per share |
2023-11-17 | Palmin Harry S | Sell | 125 000 | Common Stock, $0.0001 par value per share |
INSIDER POWER |
---|
-68.02 |
Last 96 transactions |
Buy: 5 870 002 | Sell: 3 622 222 |
Volum Korrelasjon
Acer Therapeutics Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
BIRD | 0.965 |
CNTY | 0.965 |
COLB | 0.964 |
FTXO | 0.963 |
KBWB | 0.962 |
AIRG | 0.961 |
FITB | 0.961 |
CPTN | 0.96 |
PRCH | 0.958 |
EVLO | 0.957 |
10 Mest negative korrelasjoner | |
---|---|
OPNT | -0.949 |
DVCR | -0.944 |
DSEY | -0.941 |
AMYT | -0.935 |
CCRC | -0.933 |
SUMO | -0.93 |
DAKT | -0.919 |
SGEN | -0.918 |
BTBD | -0.917 |
PPYAU | -0.913 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Acer Therapeutics Inc Korrelasjon - Valuta/Råvare
Acer Therapeutics Inc Økonomi
Annual | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-1.770 |
FY | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-1.770 |
FY | 2021 |
Omsetning: | $1.26M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-1.080 |
FY | 2020 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-2.06 |
Financial Reports:
No articles found.
Acer Therapeutics Inc
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.